Literature DB >> 8515067

Regulation of the expression of human C epsilon germline transcript. Identification of a novel IL-4 responsive element.

T Ichiki1, W Takahashi, T Watanabe.   

Abstract

Transcriptional regulation for Ig H chain germline transcripts induced by cytokines is a topic of recent interest for the understanding of the mechanism of class switch recombination. Among human B cell lines examined, we have found that a human IgM-producing B cell line, DND39 (EBV negative) expressed germ-line transcripts of epsilon constant gene (C epsilon) when stimulated with IL-4. In our study, the regulatory element responsible for the expression of IL-4-induced human C epsilon germ-line transcript was determined using DND39 cells. To identify the IL-4 responsive promoter/enhancer element, deletion analysis of the upstream region of the germ-line exon (I epsilon) of the C epsilon germ-line transcript which is located 5' to the switch region, was performed by using a luciferase gene as a reporter. Deletion analysis showed that a DNA fragment which lies between -215 and -154 bp upstream from the most 3' transcriptional initiation site of human I epsilon gene is fully responsible for the induction of germ-line transcripts by IL-4. According to a mutational analysis, the DNA fragment between -163 and -152 bp, was identified to be a novel IL-4 responsive element in a human C epsilon gene. Electrophoretic gel mobility shift assay showed the presence of IL-4-induced nuclear factor that specifically bound to this IL-4 responsive element. This novel IL-4 responsive element and an IL-4-induced DNA binding protein may play an important role for the induction of C epsilon germ-line transcript as well as class switching to IgE.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8515067

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Specialized proresolving mediators (SPMs) inhibit human B-cell IgE production.

Authors:  Nina Kim; Sesquile Ramon; Thomas H Thatcher; Collynn F Woeller; Patricia J Sime; Richard P Phipps
Journal:  Eur J Immunol       Date:  2015-11-02       Impact factor: 5.532

2.  All-trans-retinoic acid suppresses interferon-gamma and tumor necrosis factor-alpha; a possible therapeutic agent for rheumatoid arthritis.

Authors:  Yuji Nozaki; Chise Tamaki; Toshiaki Yamagata; Masafumi Sugiyama; Shinya Ikoma; Koji Kinoshita; Masanori Funauchi
Journal:  Rheumatol Int       Date:  2005-11-15       Impact factor: 2.631

3.  Isolation of differentially expressed genes upon immunoglobulin class switching by a subtractive hybridization method using uracil DNA glycosylase.

Authors:  M Sugai; S Kondo; A Shimizu; T Honjo
Journal:  Nucleic Acids Res       Date:  1998-02-15       Impact factor: 16.971

4.  Germ-line transcripts and class switching.

Authors:  J Farrant
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

5.  Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iepsilon transcription and immunoglobulin E switching.

Authors:  M B Harris; C C Chang; M T Berton; N N Danial; J Zhang; D Kuehner; B H Ye; M Kvatyuk; P P Pandolfi; G Cattoretti; R Dalla-Favera; P B Rothman
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

6.  A novel IL-4 responsive element of the E alpha MHC class II promoter that binds to an inducible factor.

Authors:  A Kretsovali; J Papamatheakis
Journal:  Nucleic Acids Res       Date:  1995-08-11       Impact factor: 16.971

7.  Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (Ig)E in the mouse.

Authors:  R A Morawetz; L Gabriele; L V Rizzo; N Noben-Trauth; R Kühn; K Rajewsky; W Müller; T M Doherty; F Finkelman; R L Coffman; H C Morse
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

8.  Characterization of an interleukin 4 (IL-4) responsive region in the immunoglobulin heavy chain germline epsilon promoter: regulation by NF-IL-4, a C/EBP family member and NF-kappa B/p50.

Authors:  S Delphin; J Stavnezer
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.